Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Horizon Discovery Group PLC    HZD   GB00BK8FL363

HORIZON DISCOVERY GROUP PLC

(HZD)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
02/11/2019 02/12/2019 02/13/2019 02/14/2019 02/15/2019 Date
174(c) 167.5(c) 170(c) 169(c) 166(c) Last
76 626 146 310 208 790 28 019 9 260 Volume
+8.07% -3.74% +1.49% -0.59% -1.78% Change
More quotes
Financials (GBP)
Sales 2018 59,0 M
EBIT 2018 -5,16 M
Net income 2018 -7,21 M
Finance 2018 18,8 M
Yield 2018 -
Sales 2019 64,5 M
EBIT 2019 -3,12 M
Net income 2019 -4,26 M
Finance 2019 15,6 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 3,91x
EV / Sales2019 3,63x
Capitalization 250 M
More Financials
Company
Horizon Discovery Group plc is a United Kingdom-based life science company. The Company uses gene editing and gene modulation application. Through the application of these technologies the Company enables researchers to alter almost any gene or modulate its function in human or mammalian cells to... 
More about the company
Surperformance© ratings of Horizon Discovery Group PL
Trading Rating : Investor Rating :
More Ratings
Latest news on HORIZON DISCOVERY GROUP PL
01/28HORIZON DISCOVERY : and Rutgers University Form Exclusive Partnership to Develop..
BU
01/21HORIZON DISCOVERY : extends CRISPR Screening Service to primary human T cells
PU
2018HORIZON DISCOVERY : Exclusive Partnership with C4X Discovery
PU
2018CELYAD : - Celyad : Announces Third Quarter 2018 Business Update
AQ
2018HORIZON DISCOVERY : announces new board appointment
PU
2018HORIZON DISCOVERY : Board Change
PU
2018HORIZON DISCOVERY : CRISPR Screening Webinar
PU
2018HORIZON DISCOVERY : partners with Biocartis to provide reference standards for r..
PU
2018HORIZON DISCOVERY TO HOST CRISPR SCR : “How gene editing is becoming embed..
PU
2018HORIZON DISCOVERY : CRISPR Screening Webinar
PU
More news
Analyst Recommendations on HORIZON DISCOVERY GROUP PL
More recommendations
Sector news : Biotechnology & Medical Research - NEC
02/15Bayer gains full Vitrakvi rights from Eli Lilly's Loxo
RE
02/12MARKET SNAPSHOT: Stocks Close At 2019 High On Tentative Deal To Avert Governm..
DJ
02/11Regeneron, Sanofi to Offer Praluent at Reduced U.S. List Price
DJ
02/11Sanofi and Regeneron cut list price of cholesterol drug by 60 percent
RE
02/06Eli Lilly Cuts Earnings Forecast on Pending Loxo Acquisition
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart HORIZON DISCOVERY GROUP PLC
Duration : Period :
Horizon Discovery Group PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HORIZON DISCOVERY GROUP PL
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 2,09  GBP
Spread / Average Target 26%
EPS Revisions
Managers
NameTitle
Terrence William Pizzie Chief Executive Officer & Executive Director
Ian David Gilham Executive Chairman
Kim Nichols Head-Global Operations
Jayesh Pankhania Chief Financial Officer & Director
Jonathan D. Moore Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
HORIZON DISCOVERY GROUP PLC-5.14%322
IQVIA HOLDINGS INC11.13%28 377
CELLTRION, INC.--.--%23 803
LONZA GROUP14.80%21 653
INCYTE CORPORATION31.18%17 908
SEATTLE GENETICS, INC.17.42%11 477